ES8304429A1 - Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol. - Google Patents
Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.Info
- Publication number
- ES8304429A1 ES8304429A1 ES508609A ES508609A ES8304429A1 ES 8304429 A1 ES8304429 A1 ES 8304429A1 ES 508609 A ES508609 A ES 508609A ES 508609 A ES508609 A ES 508609A ES 8304429 A1 ES8304429 A1 ES 8304429A1
- Authority
- ES
- Spain
- Prior art keywords
- levonantradol
- methyl
- added
- final formulation
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE SOLUCIONES MICELARES ACUOSAS ESTABLES DE LEVONANTRADOL Y N-METIL-LEVONANTRADOL. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE DISUELVE A TEMPERATURA AMBIENTE EL LEVONANTRADOL O EL N-METIL-LEVONANTRADOL, O UNA SAL DE ADICION DE ACIDO, FARMACEUTICAMENTE ACEPTABLE, DE LOS MISMOS, EN UNA SOLUCION DE UN ANFIFILO NO IONICO CON UNA CONCENTRACION MICELAR CRITICA Y EN UN VOLUMEN INFERIOR AL VOLUMEN TOTAL DE AGUA QUE HA DE ESTAR PRESENTE EN LA FORMULACION FINAL; SEGUNDA, LA SOLUCION FORMADA SE SOMETE A AGITACION; TERCERA, SE AGREGAN LOS ANTIOXIDANTES, LOS EXCIPIENTES Y LOS TAMPONES; Y POR ULTIMO, SE AJUSTA EL PH Y SE LE AÑADE EL AGUA ADICIONAL NECESARIA PARA CONSEGUIR LA CONCENTRACION DESEADA DE INGREDIENTE ACTIVO EN LA FORMULACION FINAL. DE APLICACION EN PREPARADOS FARMACEUTICOS PARA USO PARENTERAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/223,672 US4406888A (en) | 1981-01-09 | 1981-01-09 | Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution |
Publications (2)
Publication Number | Publication Date |
---|---|
ES508609A0 ES508609A0 (es) | 1983-03-01 |
ES8304429A1 true ES8304429A1 (es) | 1983-03-01 |
Family
ID=22837540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES508609A Expired ES8304429A1 (es) | 1981-01-09 | 1982-01-08 | Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4406888A (es) |
EP (1) | EP0056681A3 (es) |
JP (1) | JPS57136512A (es) |
AU (1) | AU528316B2 (es) |
CA (1) | CA1172569A (es) |
CS (1) | CS235524B2 (es) |
DK (1) | DK4382A (es) |
ES (1) | ES8304429A1 (es) |
FI (1) | FI813969L (es) |
GR (1) | GR76514B (es) |
HU (1) | HU186462B (es) |
IL (1) | IL64731A0 (es) |
NO (1) | NO820045L (es) |
NZ (1) | NZ199415A (es) |
PH (1) | PH17593A (es) |
PT (1) | PT74257B (es) |
ZA (1) | ZA82118B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE33239E (en) * | 1983-09-06 | 1990-06-26 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
US4657900A (en) * | 1983-09-27 | 1987-04-14 | Rowell Laboratories | Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
US8163797B2 (en) * | 2003-12-31 | 2012-04-24 | Actavis Elizabeth Llc | Method of treating with stable pravastatin formulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2391552A (en) * | 1942-02-25 | 1945-12-25 | Curtis David | Stabilized aromatic compounds |
BE786427A (fr) * | 1971-07-19 | 1973-01-18 | Pfizer | Compositions aqueuses de doxycycline |
SE7704749L (sv) * | 1976-05-17 | 1977-12-05 | Pfizer | Kinoliner och forfarande och mellanprodukter for framstellning derav |
HU180917B (hu) | 1976-05-17 | 1983-05-30 | Pfizer | Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására |
US4260764A (en) * | 1976-12-22 | 1981-04-07 | Pfizer Inc. | 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor |
JPS54157818A (en) * | 1978-06-02 | 1979-12-13 | Tokyo Tanabe Co | Injectionable preparation of chlorethylnitrosourea compound |
US4320124A (en) * | 1980-10-17 | 1982-03-16 | Pfizer Inc. | Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof |
-
1981
- 1981-01-09 US US06/223,672 patent/US4406888A/en not_active Expired - Lifetime
- 1981-12-10 FI FI813969A patent/FI813969L/fi not_active Application Discontinuation
-
1982
- 1982-01-04 HU HU8211A patent/HU186462B/hu unknown
- 1982-01-05 EP EP82300018A patent/EP0056681A3/en not_active Withdrawn
- 1982-01-06 NZ NZ199415A patent/NZ199415A/en unknown
- 1982-01-07 PH PH26711A patent/PH17593A/en unknown
- 1982-01-07 JP JP57001342A patent/JPS57136512A/ja active Pending
- 1982-01-07 CA CA000393740A patent/CA1172569A/en not_active Expired
- 1982-01-08 IL IL64731A patent/IL64731A0/xx unknown
- 1982-01-08 NO NO820045A patent/NO820045L/no unknown
- 1982-01-08 ZA ZA82118A patent/ZA82118B/xx unknown
- 1982-01-08 ES ES508609A patent/ES8304429A1/es not_active Expired
- 1982-01-08 PT PT74257A patent/PT74257B/pt unknown
- 1982-01-08 CS CS82174A patent/CS235524B2/cs unknown
- 1982-01-08 DK DK4382A patent/DK4382A/da not_active Application Discontinuation
- 1982-01-08 AU AU79404/82A patent/AU528316B2/en not_active Ceased
- 1982-01-08 GR GR66964A patent/GR76514B/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO820045L (no) | 1982-07-12 |
PT74257A (en) | 1982-02-01 |
HU186462B (en) | 1985-08-28 |
PT74257B (en) | 1984-05-29 |
PH17593A (en) | 1984-10-02 |
ES508609A0 (es) | 1983-03-01 |
EP0056681A3 (en) | 1983-07-20 |
DK4382A (da) | 1982-07-10 |
FI813969L (fi) | 1982-07-10 |
IL64731A0 (en) | 1982-03-31 |
JPS57136512A (en) | 1982-08-23 |
CS235524B2 (en) | 1985-05-15 |
US4406888A (en) | 1983-09-27 |
AU7940482A (en) | 1982-07-22 |
ZA82118B (en) | 1982-11-24 |
GR76514B (es) | 1984-08-10 |
EP0056681A2 (en) | 1982-07-28 |
NZ199415A (en) | 1985-04-30 |
CA1172569A (en) | 1984-08-14 |
AU528316B2 (en) | 1983-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK642587A (da) | Insulinpraeparat | |
AU3183389A (en) | Human relaxin formulation | |
AU7004387A (en) | New pharmaceutical preparations with extended release | |
GB1405088A (en) | Slow release formulation | |
YU126186A (en) | Process for making water gelating solutions of arylpropionic acid derivatives, which can be respirated through skin | |
IE891118L (en) | Topical preparation for treating otopathy | |
ES460743A1 (es) | Procedimiento para la obtencion de preparados medicinales con ph acido. | |
AU669122B2 (en) | New pyrazine derivatives, their preparation and their use | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
ES8304429A1 (es) | Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol. | |
IE791995L (en) | Formulation | |
FI962056A0 (fi) | Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan | |
DK0413793T3 (da) | Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet | |
GB2000025A (en) | Nitroimidazole formulations | |
AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
JO1195B1 (en) | Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension | |
ES8106083A1 (es) | Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada | |
JPS5762218A (en) | Ophthalmic solution | |
DK0436015T3 (da) | Farmaceutisk præparat til rektal indgift | |
ES8401074A1 (es) | Sal de n-metil-d-glucamina. | |
AU621677B2 (en) | Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same | |
Smirnova | Effect of histamine and prostaglandins E2 and F2 alpha on the electrical activity of stomach cells in the rat | |
JPS5498306A (en) | Preparation of human blood-plasma cholinesterase | |
SE9302006D0 (sv) | Protein formulation | |
JPS5520717A (en) | Saccharide-transfusing agent |